2,702 results match your criteria: "Cervical Ripening"
Health Technol Assess
December 2024
Usher Institute, University of Edinburgh, Edinburgh, UK.
Background: Around one in three pregnant women undergoes induction of labour in the United Kingdom, usually preceded by in-hospital cervical ripening to soften and open the cervix.
Objectives: This study set out to determine whether cervical ripening at home is within an acceptable safety margin of cervical ripening in hospital, is effective, acceptable and cost-effective from both National Health Service and service user perspectives.
Design: The CHOICE study comprised a prospective multicentre observational cohort study using routinely collected data (CHOICE cohort), a process evaluation comprising a survey and nested case studies (qCHOICE) and a cost-effectiveness analysis.
Medicine (Baltimore)
December 2024
Department of Obstetrics and Gynecology, Taixing People's Hospital, Taixing, China.
The timing of amniotomy after the Foley balloon catheter removal is crucial for successful labor induction. This study aimed to assess the effects of the Bishop score on the timing of amniotomy in patients undergoing labor induction after the Foley balloon catheter removal. This was a retrospective cohort study based on electronic medical records.
View Article and Find Full Text PDFActa Obstet Gynecol Scand
December 2024
Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Introduction: Pre-labor rupture of membranes (PROM) occurs in about 8% of term pregnancies with over 70% delivering spontaneously within 24 h. However, prolonged PROM increases the risk of chorioamnionitis and neonatal sepsis. While misoprostol and oxytocin are considered safe and effective methods of labor induction, most guidelines do not encourage balloon catheter (BC) use following PROM given concerns about increased risk of chorioamnionitis.
View Article and Find Full Text PDFAm J Obstet Gynecol MFM
December 2024
Department of Obstetrics and Gynecology, Faculty of Medicine, Universiti Malaya, Jalan Profesor Diraja Ungku Aziz, 50603, Kuala Lumpur, Malaysia. Electronic address:
Am J Obstet Gynecol MFM
December 2024
Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, Eastern Virginia Medical School, Norfolk, VA.
Objectives: Dilapan-S is a cervical ripening agent approved by the FDA that has been found to be just as effective as other agents and can be utilized for outpatient ripening. No large-scale studies have been conducted to compare cesarean delivery rates between Dilapan-S and other ripening methods. Our objective was to combine these trials to compare cesarean delivery rates for Dilapan-S with other cervical ripening methods, overall and in sub-groups.
View Article and Find Full Text PDFActa Obstet Gynecol Scand
December 2024
Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Introduction: Nulliparous women beyond term have high rates of induction failure. The aim of this study was to compare delivery outcomes for balloon catheter, misoprostol, and combination of both in nulliparous late- and post-term women with unfavorable cervices. We intended to explore whether the combination strategy has lower cesarean section rate and is as safe as either method alone.
View Article and Find Full Text PDFJ Midwifery Womens Health
December 2024
Fairfield University Marion Peckham Egan School of Nursing and Health Studies, Fairfield, Connecticut.
Labor after cesarean (LAC) is a safe alternative for pregnant persons who have had 1 or 2 previous cesarean births (CBs) and have no contraindication to vaginal birth. When compared with repeat CB, vaginal birth after cesarean (VBAC) reduces short- and long-term health complications and morbidity and should therefore be presented as an option. Despite recommendations from the American College of Nurse-Midwives and the American College of Obstetricians and Gynecologists in support of LAC, not all pregnant persons who are candidates have access to this option.
View Article and Find Full Text PDFEur J Obstet Gynecol Reprod Biol
December 2024
Rotunda Hospital, Dublin, Ireland; Department of Obstetrics and Gynaecology, Royal College of Surgeons in Ireland, (RCSI), University of Medicine and Health Sciences, Dublin, Ireland.
Objective: This secondary analysis evaluates the logistics of achieving vaginal delivery following outpatient induction. This includes changes in Bishop score before and after cervical ripening, the need for additional ripening agents, time interval from induction to delivery, all of which provide invaluable information when developing an outpatient induction of labour service.
Study Design: We randomised healthy nulliparous women with no significant medical history, who agreed to elective induction of labour at 39 weeks' gestation, to one of three forms of initial cervical ripening at home: 12 h of Dilapan-S, 24 h of Dilapan-S, or 24 h of slow-release dinoprostone (Propess).
Ultrasound
November 2024
Department of Radiodiagnosis, IGMC, Shimla, India.
Zhonghua Fu Chan Ke Za Zhi
November 2024
Ultrasound
November 2024
Division of Maternal and Fetal Medicine, Department of Gynaecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
PLoS One
November 2024
Department of Midwifery, College of Medicine and Health Science, Woldia University, Woldia, Ethiopia.
Am J Obstet Gynecol MFM
November 2024
Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston, TX.
Ginekol Pol
November 2024
Department of Obstetrics and Gynecology, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou, Jiangsu, P.R. China.
BMC Microbiol
November 2024
Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui Province, China.
Taiwan J Obstet Gynecol
November 2024
Department of Obstetrics and Gynecology, Nippon Medical School Musashikosugi Hospital, 1-383 Kosugi-cho, Nakahara-ku, Kawasaki, Kanagawa, Japan.
Sci Rep
October 2024
Department of Midwifery, College of Medicine and Health Science, Debre Markos University, Debre Markos, Ethiopia.
Am J Obstet Gynecol MFM
October 2024
Department of Obstetrics & Gynecology, Monash University, Monash Medical Centre, Clayton, Victoria, Australia (Patabendige, Rolnik, Li, and Mol); Women's and Newborn, Monash Health, Victoria, Australia (Patabendige, Rolnik, and Mol).
Acta Obstet Gynecol Scand
December 2024
The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
Int J Gynaecol Obstet
October 2024
Department of Obstetrics and Gynecology, Bnai-Zion Medical Center, Technion - Israel Institute of Technology, Haifa, Israel.
J Obstet Gynaecol Res
December 2024
Department of Obstetrics and Gynecology, Keio University School of Medicine, Shinjuku, Tokyo, Japan.
Am J Perinatol
October 2024
Allina Health, Minneapolis, Minnesota.
AJOG Glob Rep
November 2024
Department of Obstetrics and Gynaecology, PSGIMSR, Coimbatore, Tamil Nadu, India (Maheshwari).
Am J Obstet Gynecol MFM
December 2024
Department of Obstetrics and Gynaecology, Monash University, Faculty of Medicine, Nursing and Health Sciences, Monash Medical Centre, 246 Clayton Rd, Clayton, Victoria 3168 Australia (Seo, Davies-Tuck, Warty, Smith, and Palmer); Monash Women's, Monash Health, 246 Clayton Rd, Clayton, Victoria Australia (Palmer).